Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…

Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 20, 2025 (10:21)

Sector: Healthcare

The share price of Alnylam Pharmaceuticals, Inc. (ALNY) now

Latest session on the 17th of April for
Alnylam Pharmaceuticals, Inc. is positive
Trading Volume: 601350
Open: 230.48 /  High: 235.12 /  Low: 228.96
Current value: $234.56
What analysts predict: $315.33
52-week High/Low: $304.39 / $141.98
50-Day Moving Average: $252.72 — resistance level today
200-Day Moving Average: $259.0 — resistance level today

Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Alnylam Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Alnylam Pharmaceuticals stock

The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.

Trending Themes in the Healthcare Sector

Alnylam Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 22 242.94 238.05 248.11 4.22
Apr 23 244.61 241.31 250.12 3.65
Apr 24 246.45 242.31 250.66 3.45
Apr 25 246.97 243.26 249.26 2.47
Apr 26 243.41 238.15 248.81 4.48
Apr 27 244.43 238.71 250.00 4.73
Apr 28 241.06 238.82 243.30 1.88
Apr 29 240.77 238.89 243.87 2.09
Apr 30 237.88 234.81 240.73 2.52
May 01 237.95 236.52 239.95 1.45
May 02 236.81 233.83 241.14 3.13
May 03 240.22 237.84 244.90 2.97
May 04 244.11 240.52 249.53 3.74
May 05 250.99 247.83 255.44 3.07
May 06 250.84 247.98 255.96 3.22
May 07 256.79 254.25 262.64 3.30
May 08 261.33 256.94 263.84 2.69
May 09 265.96 261.49 269.23 2.96
May 10 268.51 262.23 274.80 4.79
May 11 271.98 268.71 275.57 2.55
May 12 268.22 262.35 271.76 3.59
May 13 260.58 255.73 266.29 4.13
May 14 267.07 261.54 273.00 4.38
May 15 273.40 269.38 279.30 3.68
May 16 272.33 268.82 276.01 2.67
May 17 277.56 274.40 280.39 2.18
May 18 271.15 265.94 277.41 4.31
May 19 267.08 262.67 272.53 3.75
May 20 269.97 266.00 275.88 3.71
May 21 269.40 267.30 273.36 2.27

Alnylam Pharmaceuticals Daily Price Targets


Alnylam Pharmaceuticals Stock Forecast 04-22-2025.

Forecast target price for 04-22-2025: $242.94.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.053%.
Pessimistic target level: 238.05
Optimistic target level: 248.11

Alnylam Pharmaceuticals Stock Forecast 04-23-2025.

Forecast target price for 04-23-2025: $244.61.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 3.521%.
Pessimistic target level: 241.31
Optimistic target level: 250.12

Alnylam Pharmaceuticals Stock Forecast 04-24-2025.

Forecast target price for 04-24-2025: $246.45.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 3.333%.
Pessimistic target level: 242.31
Optimistic target level: 250.66

Alnylam Pharmaceuticals Stock Forecast 04-25-2025.

Forecast target price for 04-25-2025: $246.97.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.408%.
Pessimistic target level: 243.26
Optimistic target level: 249.26

Alnylam Pharmaceuticals Stock Forecast 04-26-2025.

Forecast target price for 04-26-2025: $243.41.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.285%.
Pessimistic target level: 238.15
Optimistic target level: 248.81

Alnylam Pharmaceuticals Stock Forecast 04-27-2025.

Forecast target price for 04-27-2025: $244.43.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 4.517%.
Pessimistic target level: 238.71
Optimistic target level: 250.00

ALNY (ALNY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 276.43 232.31 315.90 26.46
Jun. 278.17 259.48 321.98 19.41
Jul. 282.84 243.05 300.07 19.00
Aug. 270.96 247.07 295.43 16.37
Sep. 251.62 239.46 288.61 17.03
Oct. 269.06 243.63 295.05 17.43
Nov. 306.91 285.64 352.03 18.86
Dec. 320.45 279.40 346.02 19.25

Alnylam Pharmaceuticals forecast for this year


Alnylam Pharmaceuticals Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $276.429. Pessimistic: $232.31. Optimistic: $315.90


Alnylam Pharmaceuticals Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $278.17. Pessimistic: $259.48. Optimistic: $321.98


Alnylam Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $282.844. Pessimistic: $243.05. Optimistic: $300.07


Alnylam Pharmaceuticals Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $270.964. Pessimistic: $247.07. Optimistic: $295.43


Alnylam Pharmaceuticals Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $251.617. Pessimistic: $239.46. Optimistic: $288.61


Alnylam Pharmaceuticals Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $269.055. Pessimistic: $243.63. Optimistic: $295.05


Alnylam Pharmaceuticals Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $306.91. Pessimistic: $285.64. Optimistic: $352.03


Alnylam Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $320.445. Pessimistic: $279.40. Optimistic: $346.02



Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 294.20 260.22 315.21 17.44
Feb 335.60 280.62 360.26 22.11
Mar 305.29 254.00 326.45 22.19
Apr 313.63 279.38 333.38 16.20
May 351.83 292.72 407.24 28.12
Jun 320.79 289.81 371.32 21.95
Jul 347.07 310.63 403.92 23.10
Aug 382.05 322.68 403.71 20.07
Sep 406.12 344.72 464.11 25.73
Oct 397.59 377.55 442.68 14.71
Nov 444.35 413.56 512.47 19.30
Dec 431.29 377.85 470.23 19.65

Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 383.28 343.04 404.21 15.13
Feb 405.82 387.07 424.57 8.83
Mar 360.65 310.67 419.73 25.98
Apr 422.00 379.46 458.33 17.21
May 465.42 433.17 526.02 17.65
Jun 512.34 447.78 588.73 23.94
Jul 559.68 529.12 621.97 14.93
Aug 613.74 531.26 645.96 17.76
Sep 568.63 496.98 648.64 23.38
Oct 563.86 501.10 630.17 20.48
Nov 478.60 439.40 504.73 12.94
Dec 476.59 425.55 499.61 14.82

Alnylam Pharmaceuticals information and performance

Alnylam Pharmaceuticals Address

675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Market Capitalization: 29 832 923 000 $

Market capitalization of the Alnylam Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALNY shares in the company outstanding by the market price of one share.

EBITDA: -120 215 000 $

EBITDA of Alnylam Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.49

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.19

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.349
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 833.33

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 12.67

Enterprise Value (EV) /Revenue

EV To EBITDA: 204.85

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 129427000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Alnylam Pharmaceuticals Stock)

Should I Buy Alnylam Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $444.35, which is $209.79 higher than the current stock price. By investing in Alnylam Pharmaceuticals shares today for a one-year period, you could achieve a profit of 89.44%. With an investment horizon of up to two years, the target share price is $613.74. resulting in a profit of 161.66% ($379.18 per share).

Does Alnylam Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Alnylam Pharmaceuticals's shares belong to?

Alnylam Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Alnylam Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Alnylam Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.